Trials / Completed
CompletedNCT00623051
Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27,000 (actual)
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis · Other Government
- Sex
- Male
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study is aimed at demonstrating whether or not Male Circumcision can be used as an effective public health prevention tool that will have an impact on HIV prevalence in the South African population.
Detailed description
A randomized, controlled trial (ANRS 1265) conducted in Orange Farm (South Africa) has demonstrated that male circumcision (MC) can reduce the risk of HIV acquisition by more than 50% among young men. This result has been confirmed by two similar studies conducted in Uganda and in Kenya. Giving these findings, the next logical step is to demonstrate whether or not MC can be used as an effective public health prevention tool that will have an impact on HIV in populations as well as among individuals. This research study aims to establish a MC intervention in the community where the first randomized controlled trial of the impact of MC on men's risk of acquiring HIV infection was carried out in order to evaluate its impact on: 1. knowledge, attitudes and practice regarding MC 2. existing means of prevention (sexual behavior change, condom use, STI treatment-seeking behavior and VCT (voluntary counseling and testing) attendance) 3. the spread of HIV and HSV-2 This research will be carried out over a period of 60 months and will have three major components: (1) the delivery of the intervention, (2) quantitative studies (cross-sectional surveys), and (3) qualitative studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Male Circumcision |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2008-02-25
- Last updated
- 2013-07-17
Locations
1 site across 1 country: South Africa
Source: ClinicalTrials.gov record NCT00623051. Inclusion in this directory is not an endorsement.